[Computed tomographic brain scanning in the diagnosis of metastatic neoplasms (author's transl)]
Standard
[Computed tomographic brain scanning in the diagnosis of metastatic neoplasms (author's transl)]. / Ringelstein, E B; Zeumer, Hermann; Hacke, W; Keulers, P.
In: DEUT MED WOCHENSCHR, Vol. 106, No. 47, 47, 1981, p. 1566-1571.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Computed tomographic brain scanning in the diagnosis of metastatic neoplasms (author's transl)]
AU - Ringelstein, E B
AU - Zeumer, Hermann
AU - Hacke, W
AU - Keulers, P
PY - 1981
Y1 - 1981
N2 - Clinical investigations and computed brain scanning were done in 305 patients with primary extracerebral malignant tumours. One third of the patients had cerebral metastases. In most patients with brain metastases extracerebral secondary tumours were known already. Silent brain metastases were present in only 0.6% of all investigated tumour patients. All other patients had either objective neurologic-psychiatric defects or a least symptoms (headache, vomiting). Use of cranial computed tomography in all tumour patients as a pure screening method is thus not justified. The indication for the investigation is dependent on the clinical symptomatology. However, not only objective neurologic-psychiatric defects must be taken into account, but also occurrence of new symptoms.
AB - Clinical investigations and computed brain scanning were done in 305 patients with primary extracerebral malignant tumours. One third of the patients had cerebral metastases. In most patients with brain metastases extracerebral secondary tumours were known already. Silent brain metastases were present in only 0.6% of all investigated tumour patients. All other patients had either objective neurologic-psychiatric defects or a least symptoms (headache, vomiting). Use of cranial computed tomography in all tumour patients as a pure screening method is thus not justified. The indication for the investigation is dependent on the clinical symptomatology. However, not only objective neurologic-psychiatric defects must be taken into account, but also occurrence of new symptoms.
M3 - SCORING: Zeitschriftenaufsatz
VL - 106
SP - 1566
EP - 1571
JO - DEUT MED WOCHENSCHR
JF - DEUT MED WOCHENSCHR
SN - 0012-0472
IS - 47
M1 - 47
ER -
